Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapoxetine and Mirodenafil Interaction in Healthy Males
NCT02485028Phase 1Completed
- Sponsor
- SK Chemicals
- Start
- Oct 2013
- Primary completion
- Nov 2013
- Modality
- Covalent Small Molecules, Orthosteric Ligands
01
Overview
Phase 1, randomised, open-label trial of dapoxetine and mirodenafil in premature ejaculation (PE) and erectile dysfunction (ED), sponsored by SK Chemicals. Started Oct 2013; status: completed.
02
Drugs
dapoxetinemirodenafil
03
Conditions
premature ejaculation (PE)erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT02485028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02485028.